ICGvHSI: ICG vs. HSI in Gastrointestinal Resections

Sponsor
University of Leipzig (Other)
Overall Status
Unknown status
CT.gov ID
NCT04226781
Collaborator
(none)
50
1
2
17.6
2.8

Study Details

Study Description

Brief Summary

In this study, gastrointestinal anastomoses are examined with a hyperspectral camera and after this the investigators use the Standard Routine ICG-Imaging. At the end, both methods will be compared..

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Hyperspectral-Imaging
  • Diagnostic Test: Indocyaningreen-Fluorescence imaging
N/A

Detailed Description

All gastrointestinal anastomoses were examined in all patients with written informed consent.

As Standard in our clinical Routine the tissue perfusion is measured with fluorescence Imaging and Indocyaningreen (ICG). In this study the investigators use the Hyperspectral-Camera (HSI-Camera) as new method. The measurements were performed like described before, using the TIVITA Tissue system (Diaspective Vision GmbH, Am Salzhaff, Germany). This HSI-camera provides hyperspectral images with a high spectral resolution (5 nm) in the visible and near infrared range (500-1000 nm). A RGB image and 4 false color images that represent physiologic parameters are intraoperatively provided by an analysis software. This work is focused on tissue oxygenation (StO2), which represents the relative blood oxygenation in the microcirculation of superficial tissue layers (approximately 1 mm) and the near-infrared (NIR) Perfusion Index, representing tissue layers in 4-6 mm penetration depth.

As Standard method ICG-Fluorescence Imaging is used. After the procedure the Perfusion data of both Systems is compared.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Comparison Between Fluorescenceimaging With Indocyaningreen (ICG) and Hyperspectralimagig (HSI) for Tissue Perfusion in Gastrointestinal Resections
Actual Study Start Date :
Jan 2, 2020
Anticipated Primary Completion Date :
Dec 31, 2020
Anticipated Study Completion Date :
Jun 20, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: ICG

Fluorescence imaging for blood Perfusion of the gastrointestinal tissue

Diagnostic Test: Indocyaningreen-Fluorescence imaging
Photos were taken with the Fluorescence camera after injection of the indocyaningreen-dye of the gastrointestinal anastomosis

Experimental: HSI

Hyperspectralimaging for blood Perfusion of the gastrointestinal tissue

Diagnostic Test: Hyperspectral-Imaging
Photos were taken with the hyperspectral camera of the gastrointestinal anastomosis.

Outcome Measures

Primary Outcome Measures

  1. Tissue oxygenation (StO2) in % [After the intraoperative Photo is taken, within 5 minutes]

    Directly after the photo has been taken, the distribution of the spectra and their intensity is evaluated with the help of computer assisted analysis software. The software calculates the tissue oxygen saturation value (StO2) in percent. These values are measured at a standardized distance from the anastomosis region.

  2. Anastomotic Perfusion in arbitrary units [After the intraoperative Photo is taken, within 5 minutes]

    Directly after the photo has been taken, the distribution of the spectra and their intensity is evaluated with the help of computer assisted analysis software. The software calculates the tissue perfusion in arbitrary units. (Method is described in attached literature) These values are measured at a standardized distance from the anastomosis region.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • all gastrointestinal anastomoses
Exclusion Criteria:
  • inability to consent

  • allergy against indocyaningreen dye

Contacts and Locations

Locations

Site City State Country Postal Code
1 Universitätsklinikum Leipzig - AöR Leipzig Sachsen Germany 04103

Sponsors and Collaborators

  • University of Leipzig

Investigators

  • Principal Investigator: Boris Jansen-Winkeln, MD, PD, University of Leipzig

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Dr. Boris Jansen-Winkeln, Principal Investigator, Deputy Head of Department, Priv.-Doz. Dr. med. habil., University of Leipzig
ClinicalTrials.gov Identifier:
NCT04226781
Other Study ID Numbers:
  • 202001
First Posted:
Jan 13, 2020
Last Update Posted:
Mar 16, 2020
Last Verified:
Mar 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dr. Boris Jansen-Winkeln, Principal Investigator, Deputy Head of Department, Priv.-Doz. Dr. med. habil., University of Leipzig

Study Results

No Results Posted as of Mar 16, 2020